SEC Form 4 · accession 0001193125-26-390650
TransMedics Group, Inc. · TMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Weill
Director
Period of report
Sep 11, 2026
Accepted (ET)
Sep 14, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001756262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2026 | P | 1,336 | $81.63 | A | 16,392 | D |
Table II — derivative securities
No Table II lines on this filing.